Navigation Links
Bone-Breaking News: Mayo Clinic Solves Mysterious Link Between Diabetes and Osteoporosis
Date:11/14/2013

SANTA BARBARA, Calif., Nov. 14, 2013 /PRNewswire-iReach/ -- Mayo Clinic, the world's leading medical center, discovered bone deterioration is yet another complication of diabetes. The discovery was enabled by a new medical device, OsteoProbe®, developed by Active Life Scientific, Inc. in Santa Barbara, California. 

OsteoProbe® is designed to measure the material properties of bone as a signature of bone strength, and as a target for new treatments and disease prevention.  A growing body of scientific evidence is attracting an A-list of global customers and collaborators to the medical value of the company's novel technology.

"We congratulate Dr. Khosla and his top-notch team for this vital contribution to medical knowledge," says Davis Brimer, Active Life Chief Executive Officer.  "These important findings further validate the significance of material properties to bone strength."

"This is the first demonstration – using direct measurement of bone strength in the body – of compromised bone material in patients with type 2 diabetes," says Sundeep Khosla, M.D., Mayo Clinic endocrinologist, senior author of the study. 

It is known that a patient with diabetes has a higher fracture risk than a non-diabetic, what is not known is why.  The gold-standard method for diagnosing fracture risk is a bone density scan to determine how much bone there is, however that method is ineffective because diabetics have the same bone density as non-diabetics.  The study suggests a deterioration of bone material properties may indicate a greater risk of fracture.

For more information about this research study, please visit the Mayo Clinic featured YouTube media release and original Press Release.

About Active Life
Active Life Scientific, Inc. is enabling cutting edge science and technology to help people live a long and active life.  Their flagship products, OsteoProbe® and BioDent™, are being used worldwide by the most innovative and thought leading scientists and physicians working hard to extend your active life.  The company's technology introduces unrivaled direct measures of the health of tissues in patients before deteriorating and negatively impacting quality of life.  The Company's products are based on world renowned inventor Professor Paul Hansma's latest breakthrough, Reference Point Indentation. www.activelifescientific.com

About Mayo Clinic

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news

Media Contact: Jennifer Rios, Active Life Scientific, Inc., +1.805.770.2600 x102, jen@activelifescientific.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Active Life Scientific, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD
2. Yaz Settlement Funding News: 10K Cases Still Not Settled
3. DePuy Hip Recall Settlement News: First Federal Trial To Begin This Week
4. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
5. DePuy Settlement News: J&J Wins Major Verdict In Illinois Trial
6. Wright, Biomet, Stryker Hip Recall Settlement Funding News: Legal-Bay To Increase Funding Amounts Up to $50K
7. Transvaginal Mesh Settlement Funding News: Legal-Bay To Increase Funding Amounts Up to $250K On Some Vaginal Mesh and Bladder Sling Recall Cases
8. DePuy Settlement Funding News: Legal-Bay To Increase Funding Amounts Up to $250K On Some DePuy Hip Recall Cases
9. Breaking News: Video Interview With Harry Zhabilov of Immunotech Laboratories Inc.
10. Gateway Foundation Warns K2 is Bad News: K2 Poses Serious Health Risks
11. DelMar Pharmaceuticals to Present Interim Clinical Data for VAL-083 in Glioblastoma at Society of Neuro-Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)...  Arcturus Therapeutics, Inc. ("Arcturus" or the "Company"), ... it entered into collaboration with Takeda Pharmaceutical Company ... of NASH and other gastrointestinal (GI) related disorders, ... UNA Oligomer chemistry. The financial terms were not ... and expertise in GI disorders, we are confident ...
(Date:12/6/2016)... , Dec. 6, 2016 A new study ... of 340B (AIR 340B) projects the 340B Drug Pricing Program ... by which time it is expected to exceed $23 billion ... would see 340B purchases surpass current Medicare Part B drug ... The new study – based on analysis of data on ...
(Date:12/6/2016)... Tenn , Dec. 6, 2016  In response ... dependent on opioids every 25 minutes, a respected group ... company that will provide a holistic suite of services ... Based on his own experience trying to ... social entrepreneur Justin Lanning launched 180 ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... , ... December 07, 2016 , ... The medical profession ... and winter seasons. One major study analyzing heart attacks among 138,602 people recorded ... of a given year. We would all agree of course–no time of year is ...
(Date:12/7/2016)... ... ... “The Road To Restoration”: an informative and enlightening book for those who believe ... hands. “The Road To Restoration” is the creation of published author, Thomas Fitzhugh Sheets, ... that you could reach out for, and grab, on the old carousels. If ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, 2017. ... will share a range of experiences from a cross-section of industries such as ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... have agreed to collaborate in developing a vaccine against the Middle East Respiratory ... vaccine can be available in South Korea for emergency deployment in the event ...
Breaking Medicine News(10 mins):